• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    More On RVX.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Resverlogix Corp. (RVX.TO)

    -Toronto
    0.82 Down 0.05(5.75%) Feb 27, 3:49PM EST
    Add to Portfolio
    Prev Close:0.87
    Open:0.87
    Bid:0.79
    Ask:0.82
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.75 - 0.88
    52wk Range:0.41 - 1.00
    Volume:236,144
    Avg Vol (3m):56,926
    Market Cap:70.27M
    P/E (ttm):3.60
    EPS (ttm):0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Apr-15) :-0.14
    Quarterly EPS Est (Jan-15) :-0.04
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Resverlogix Corp., a clinical stage biotechnology company, develops small molecules that selectively inhibit Bromodomain and ExtraTerminal domain proteins for high risk vascular diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback